Treace Medical Concepts

TMCI · NASDAQ

$4.07+$0.19 (+4.90%)TodayMarket closed ·
Prev close $3.88

About TMCI

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. The company is headquartered in Ponte Vedra, Florida and currently employs 450 full-time employees. The company went IPO on 2021-04-23. The company is advancing the standard of care for the surgical management of bunion and related midfoot deformities. The company has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. The company has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. The company sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Employees
450
Headquarters
Ponte Vedra, Florida
Listed
Apr 23, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
treace.com

TMCI key statistics

Market cap
264.69M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
226.46K
Volume
184.22K
Open price
$3.92
High today
$4.09
Low today
$3.88
52 Week high
$7.08
52 Week low
$1.17

Treace Medical Concepts (TMCI) at a glance

Treace Medical Concepts (TMCI) last traded at $4.07, with a market cap of 264.69M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.88 and $4.09. The current price is 5.0% above the day's low and 0.4% below its high.

Volume so far is 184.22K shares, in line with the average of 226.46K shares a day.

Over the past year Treace Medical Concepts has ranged from $1.17 to $7.08, and now sits 49% of the way up that range.

Treace Medical Concepts met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported -$0.24 per share against an estimate of -$0.304.

The average analyst price target is $5.61, 37.8% above the current price, from 6 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

17%of 6 analyst ratings say Buy
  • Buy16.7%
  • Hold66.7%
  • Sell16.7%
Price target · 5 analystsAvg $5.61
Low
$4.55
Now
$4.07
High
$7.35

TMCI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 18.8% on average.

  1. Q3 FY24: reported -$0.25 per share against an estimate of -$0.2771
  2. Q4 FY24: reported -$0.01 per share against an estimate of -$0.0393
  3. Q1 FY25: reported -$0.25 per share against an estimate of -$0.3075
  4. Q2 FY25: reported -$0.28 per share against an estimate of -$0.2941
  5. Q3 FY25: reported -$0.26 per share against an estimate of -$0.2856
  6. Q4 FY25: reported -$0.15 per share against an estimate of -$0.153
  7. Q1 FY26: reported -$0.28 per share against an estimate of -$0.3142
  8. Q2 FY26: reported -$0.24 per share against an estimate of -$0.304

TMCI news

  • Press releasePRNewswire

    Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releasePRNewswire

    Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Avi Kapoor

    US Stocks Mixed; Dow Falls Over 100 Points

  • Press releaseGlobe Newswire

    Johnson Fistel, PLLP Investigates Claims on Behalf of Long‑Term Shareholders of Quantum Computing Inc. (QUBT), Quanex Building Products Corporation (NX), Treace Medical Concepts, Inc. (TMCI), and BigBear.ai Holdings, Inc. (BBAI)

  • The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts

  • 12 Health Care Stocks Moving In Friday's After-Market Session

  • Avi Kapoor

    Nasdaq Tumbles Over 100 Points; US Consumer Sentiment Falls In November

  • 12 Health Care Stocks Moving In Friday's Intraday Session

Similar companies

Companies in the same industry as Treace Medical Concepts

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.